Cargando…
Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction
A bispecific antibody (bsAb) is a class of engineered antibody molecules that simultaneously binds to two different antigens by having two kinds of antigen-binding domains. One of the major obstacles for the bsAb production is the incorrect chain-pairing problem, wherein each heavy and light chain s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520027/ https://www.ncbi.nlm.nih.gov/pubmed/37749185 http://dx.doi.org/10.1038/s41598-023-43110-0 |
_version_ | 1785109821405528064 |
---|---|
author | Yamada, Risa Nakahara, Ishin Kumagai, Izumi Asano, Ryutaro Nakanishi, Takeshi Makabe, Koki |
author_facet | Yamada, Risa Nakahara, Ishin Kumagai, Izumi Asano, Ryutaro Nakanishi, Takeshi Makabe, Koki |
author_sort | Yamada, Risa |
collection | PubMed |
description | A bispecific antibody (bsAb) is a class of engineered antibody molecules that simultaneously binds to two different antigens by having two kinds of antigen-binding domains. One of the major obstacles for the bsAb production is the incorrect chain-pairing problem, wherein each heavy and light chain should form pairings with the correct counterpart’s chains, but the structural similarity of the incorrect partners also forms the incorrect pairings. This study aimed to demonstrate a bsAb construction method using intein-mediated protein trans-splicing to create IgG–Fab(2)–type bsAbs, which is a modified antibody with a structure in which two additional Fabs are linked to the N-terminus of the heavy chain of an IgG molecule. The chain-paring problem between a heavy chain and a light chain is circumvented by separate expression and purification of the IgG part and the Fab part. We found that the deletion of a possible glycosylation residue improved the reaction yield and side-reaction cleavage in the protein ligation step. The resulting bsAb, IgG–Fab(2) (Her2/CD3), demonstrated target binding activity and cytotoxicity mediated by activated T cells. These results indicate that the use of the protein ligation to produce the IgG–Fab(2) type bsAb will expand the bsAb production method. |
format | Online Article Text |
id | pubmed-10520027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105200272023-09-27 Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction Yamada, Risa Nakahara, Ishin Kumagai, Izumi Asano, Ryutaro Nakanishi, Takeshi Makabe, Koki Sci Rep Article A bispecific antibody (bsAb) is a class of engineered antibody molecules that simultaneously binds to two different antigens by having two kinds of antigen-binding domains. One of the major obstacles for the bsAb production is the incorrect chain-pairing problem, wherein each heavy and light chain should form pairings with the correct counterpart’s chains, but the structural similarity of the incorrect partners also forms the incorrect pairings. This study aimed to demonstrate a bsAb construction method using intein-mediated protein trans-splicing to create IgG–Fab(2)–type bsAbs, which is a modified antibody with a structure in which two additional Fabs are linked to the N-terminus of the heavy chain of an IgG molecule. The chain-paring problem between a heavy chain and a light chain is circumvented by separate expression and purification of the IgG part and the Fab part. We found that the deletion of a possible glycosylation residue improved the reaction yield and side-reaction cleavage in the protein ligation step. The resulting bsAb, IgG–Fab(2) (Her2/CD3), demonstrated target binding activity and cytotoxicity mediated by activated T cells. These results indicate that the use of the protein ligation to produce the IgG–Fab(2) type bsAb will expand the bsAb production method. Nature Publishing Group UK 2023-09-25 /pmc/articles/PMC10520027/ /pubmed/37749185 http://dx.doi.org/10.1038/s41598-023-43110-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Yamada, Risa Nakahara, Ishin Kumagai, Izumi Asano, Ryutaro Nakanishi, Takeshi Makabe, Koki Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction |
title | Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction |
title_full | Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction |
title_fullStr | Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction |
title_full_unstemmed | Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction |
title_short | Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction |
title_sort | construction of igg–fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520027/ https://www.ncbi.nlm.nih.gov/pubmed/37749185 http://dx.doi.org/10.1038/s41598-023-43110-0 |
work_keys_str_mv | AT yamadarisa constructionofiggfab2bispecificantibodyviainteinmediatedproteintranssplicingreaction AT nakaharaishin constructionofiggfab2bispecificantibodyviainteinmediatedproteintranssplicingreaction AT kumagaiizumi constructionofiggfab2bispecificantibodyviainteinmediatedproteintranssplicingreaction AT asanoryutaro constructionofiggfab2bispecificantibodyviainteinmediatedproteintranssplicingreaction AT nakanishitakeshi constructionofiggfab2bispecificantibodyviainteinmediatedproteintranssplicingreaction AT makabekoki constructionofiggfab2bispecificantibodyviainteinmediatedproteintranssplicingreaction |